The Nasdaq and S&P 500 extended their weekly winning streaks to five on Friday, and the IBD 50 outperformed, notching a weekly gain of 1.5%. That’s all well and good, but institutional investors still seem reticent to add growth stocks to their portfolio.
When it comes to overall market health, things don’t look too bad, although it’s still an uncertain market where sellers can gain control quickly.